Nanomaterials for Cancer Diagnostics and Therapeutics
Northwestern University

Center Overview

Under the co-leadership of Drs. Chad Mirkin, driving the nanotechnology effort, and Steven Rosen, driving the clinical translational oncology effort, the NU-CCNE represents a strongly integrated partnership between the International Institute for Nanotechnology and the Robert H. Lurie Comprehensive Cancer Center. The primary goal of this new NU-CCNE program is to advance nanotechnology discoveries (e.g., materials, tools, and devices) for brain, breast, and pancreatic cancer diagnostics, imaging, and therapeutics that have strong potential for clinical utility and for use in many other forms of cancer research and treatment.

Center Investigators

Chad A. Mirkin, Ph.D.
Principal Investigator

Steven T. Rosen, M.D.
Principal Investigator

For more information about the Northwestern University Center of Cancer Nanotechnology Excellence visit our website at: http://www.ccne.northwestern.edu/.

View all Alliance News

Affiliated Institutions

Projects

Project 1: NanoFlares for the Detection of Cancer Stem Cells
Project 2: Theranostic Magnetic Nanostructures for the Molecular Imaging of Cancer
Project 3: Nanostructured Matrices for Cancer Cell Biology
Project 4: Preclinical Validation of Polyvalent siRNA Gold Nanoparticle Conjugates as Anti-glioma Therapeutics

Cores